Poster | 6th Internet World Congress for Biomedical Sciences |
Francisca Mulero(1), V. Roca(2), F. Nicolás(3), Francisca Mulero(4), J.A. Nuño de la Rosa(5)
(1)(4)(5)Hospital Universitario Virgen de la Arrixaca - San Miguel de Salinas. Spain
(2)(3)Servicio de Medicina Nuclear. Hospital Universitario Virgen de la Arrixaca (Murcia) - Murcia. Spain
[Oncology] |
[Radiology & Nuclear Medicine] |
Patients: 84 female patients with diagnosed breast carcinoma (52.1 ± 12.7)(age 22-81 years). All patients were scheduled for radical surgery.
Method: 99mTc-MIBI imaging according to the protocol in our institution: 740-925 MBq (Cardiolite® from DuPont Pharma) injected EV in an antecubital vein contralateral to the breast undergoing evaluation.
Planar images. 256 x 256 pixels (0.2210 cm/pixel) in a single head gammacamera with LEHR collimator. 10% window centered at Technetium´s photopeak. Prone position. Special positioning device. Imaging 5 and 90 minutes after injection for 10 minutes or 1,500 kcts.
99mTc-MIBI semiquantitative analysis:
ROI drawn over the uptake area. Total counts divided into the number of pixels yielded a mean value per pixel (T). A similar ROI over background activity was B value.
Tumor-to-background uptake ratio (T/B) was calculated in all patients.
Early (5 minutes) and delayed (1 hour) (E/D) difference in uptake was calculated with the formula:
E/D=log n early T/B - log n delayed T/B
Histopathological study:
Tumor size.
Presence or absence of axillar lymph node metastases.
Histological Degree (Scarff Bloom Richardson).
Nuclear Degree.
Mitotic Index.
Cellular Atypia.
Oestrogen receptor expression.
Statistical Analysis: The significance of proportions was evaluated by Fisher´s exact test. Comparison of MIBI uptake with different prognostic factors was made with ANOVA test and mean comparisons with a t-Student test.
[Oncology] |
[Radiology & Nuclear Medicine] |